Susquehanna International Group, LLP Edwards Lifesciences Corp Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $8.34 Million - $13.1 Million	139,700 Added 40.19%	487,300 $32.2 Million
Q2 2024 Aug 15, 2024	BUY	$84.3 - $94.31 $4.94 Million - $5.53 Million	58,600 Added 20.28%	347,600 $32.1 Million
Q1 2024 May 07, 2024	BUY	$72.54 - $95.56 $841,464 - $1.11 Million	11,600 Added 4.18%	289,000 $27.6 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $431,970 - $544,320	-7,000 Reduced 2.46%	277,400 $21.2 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $7 Million - $9.44 Million	101,100 Added 55.16%	284,400 $19.7 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $2.84 Million - $3.29 Million	-34,900 Reduced 15.99%	183,300 $17.3 Million
Q1 2023 May 16, 2023	SELL	$74.26 - $84.51 $12 Million - $13.7 Million	-161,800 Reduced 42.58%	218,200 $18.1 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $259,540 - $332,272	3,800 Added 1.01%	380,000 $28.4 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $4.04 Million - $5.27 Million	49,100 Added 15.01%	376,200 $31.1 Million

1,350

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.